Home
About
- About Molecure S.A.
- Our Team
R&D
Patients
Investors & media
Careers
Contact

Inhibition of CHIT1 as a novel therapeutic approach in idiopathic pulmonary fibrosis

About us

Molecure is an innovative biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics for neoplastic and inflammatory diseases.